| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA615193 | F | Effective dose required for inhibitory activity against 1A9 human tumor cell line. | Homo sapiens | 26 | cell-based format | Scientific Literature | ||
| 2. | ALA619573 | F | Effective dose required for inhibitory activity against A549 human tumor cell line. | Homo sapiens | 27 | cell-based format | Scientific Literature | ||
| 3. | ALA652537 | F | Effective dose required for inhibitory activity against CAK1 human tumor cell line | Homo sapiens | 21 | cell-based format | Scientific Literature | ||
| 4. | ALA689359 | F | Effective dose required for inhibitory activity against HCT-8 human tumor cell line. | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
| 5. | ALA689326 | F | Effective dose required for inhibitory activity against HOS human tumor cell line. | Homo sapiens | 23 | cell-based format | Scientific Literature | ||
| 6. | ALA702350 | F | Effective dose required for inhibitory activity against KB human tumor cell line. | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
| 7. | ALA704645 | F | Effective dose required for inhibitory activity against KB-VIN human tumor cell line. | Homo sapiens | 28 | cell-based format | Scientific Literature | ||
| 8. | ALA700711 | F | Cytotoxic activity against human epidermoid carcinoma cells (KB) | Homo sapiens | 9 | assay format | Scientific Literature | ||
| 9. | ALA708809 | F | Cytotoxic activity against mouse lymphocytic leukemia cells (L1210) | Mus musculus | 8 | cell-based format | Scientific Literature | ||
| 10. | ALA712001 | F | Effective dose required for inhibitory activity against MCF-7 human tumor cell line. | Homo sapiens | 24 | cell-based format | Scientific Literature | ||
| 11. | ALA747966 | B | Inhibition of NADH decylubiquinone (DB) oxidoreductase activity. | Bos taurus | 23 | assay format | Scientific Literature | ||
| 12. | ALA749252 | B | Inhibition of NADH oxidase activity. | Bos taurus | 23 | protein complex format | Scientific Literature | ||
| 13. | ALA761168 | F | Effective dose required for inhibitory activity against PC-3 human tumor cell line. | Homo sapiens | 27 | cell-based format | Scientific Literature | ||
| 14. | ALA762582 | F | Effective dose required for inhibitory activity against PTX10 human tumor cell line | Homo sapiens | 11 | cell-based format | Scientific Literature | ||
| 15. | ALA809847 | F | Effective dose required for inhibitory activity against SK-MEL-2 human tumor cell line. | Homo sapiens | 23 | cell-based format | Scientific Literature | ||
| 16. | ALA819511 | F | Cytotoxic activity against african green monkey (Cercopithecus aethiops) kidney epithelial cells (VERO) | Chlorocebus sabaeus | 9 | cell-based format | Scientific Literature | ||
| 17. | ALA852379 | B | Ratio of IC50 of DB to that of NADH oxidase | 23 | assay format | Scientific Literature | |||
| 18. | ALA847865 | B | Percent of relative potency by NADH oxidase assay | 15 | assay format | Scientific Literature | |||
| 19. | ALA848760 | B | Relative potency of inhibition of NADH oxidase (IC50); 4-dehydroxy-4-hydroxylimonorolliniastatin-1 as standard | Bos taurus | 23 | protein complex format | Scientific Literature | ||
| 20. | ALA1000960 | F | Cytotoxicity against mouse L1210 cells | Mus musculus | 1 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!